Kristin Russo
Women's Health · Slidell, LANPI 1174971394
Payments from drug & device makers
Across 32 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$50
- Organon$49
- AbbVie$47
- Mayne Pharma Commercial LLC$47
- Exeltis, USA Inc.$35
- Millicent US Inc$32
- plus $209 from 11 others
What the payments were for
- Food & beverage$469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Organon | 5 | $49 |
| AbbVie | 2 | $47 |
| Mayne Pharma Commercial LLC | 4 | $47 |
| Exeltis, USA Inc. | 2 | $35 |
| Millicent US Inc | 2 | $32 |
| Myovant Sciences Inc. | 2 | $30 |
| Evofem Biosciences, Inc. | 3 | $28 |
| Scynexis, Inc. | 1 | $21 |
| Aspira Women's Health Inc | 1 | $19 |
| Avion Pharmaceuticals | 1 | $19 |
| BD | 1 | $18 |
| Coloplast | 1 | $17 |
| Bayer | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Amgen | 1 | $14 |
| Vertex | 1 | $13 |
How this compares
$469 in reported general payments places this provider in the 45th percentile of 128 women's health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 41 | $984 |
| Estradiol (Twice Weekly)Estradiol | 14 | $659 |
| ProgesteroneProgesterone, Micronized | 13 | $433 |
| ValacyclovirValacyclovir Hcl | 12 | $349 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $193 |
| Clobetasol Propionate | 11 | $187 |
| Alendronate Sodium | 15 | $168 |
| Fluconazole | 19 | $116 |
Paid to pharmacies, not to this prescriber.
Other women's health in Slidell
- Amanda HayesShreveport$51K
- Nancy WellsBossier City$47K
- Ann JoplingMonroe$16K
- Kendra Joseph-RodgersNew Orleans$10K
- Aundria CannonLafayette$5K
- Jordan ForsthoffLafayette$5K
- Jennifer MillerMonroe$4K
- Alysha HinsonShreveport$4K
- Christie WaltersMonroe$4K
- Kristen MuhoberacMetairie$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.